Detalles de la búsqueda
1.
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
Gynecol Oncol
; 141(3): 454-460, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26975901
2.
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
Br J Haematol
; 181(2): 264-267, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28419407
3.
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium.
Invest New Drugs
; 30(3): 1211-5, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21552992
4.
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia.
Gynecol Oncol
; 117(1): 37-40, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20117828
5.
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer.
Clin Cancer Res
; 25(10): 2988-2995, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30224341
6.
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent.
Cancer Genet
; 224-225: 12-20, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29778231
7.
Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
Head Neck
; 39(3): E40-E44, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28006087
8.
The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases.
Fam Cancer
; 16(3): 395-399, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27866340
9.
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
J Thorac Oncol
; 12(6): 932-942, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28315738
10.
Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer.
Cancer Chemother Pharmacol
; 78(4): 815-24, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566701
11.
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
J Clin Oncol
; 21(5): 914-20, 2003 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12610193
12.
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
Am J Clin Oncol
; 25(6): 547-51, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12477995
13.
A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer.
Cancer Med
; 3(4): 988-97, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24905030
14.
Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors.
J Thorac Oncol
; 5(12): 1994-8, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20975604
15.
Small interfering RNA-directed knockdown of uracil DNA glycosylase induces apoptosis and sensitizes human prostate cancer cells to genotoxic stress.
Mol Cancer Res
; 7(8): 1285-93, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19671688
16.
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Invest New Drugs
; 24(2): 141-9, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16514482
17.
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
Cancer
; 103(1): 111-8, 2005 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15558814
Resultados
1 -
17
de 17
1
Próxima >
>>